RUNX2 and osteosarcoma: Considering that silencing of RUNX2 enhances ADR sensitivity of osteosarcoma U2OS cells through the stimulation of p53/TAp73-dependent cell death pathway,47,48 we asked whether depletion of the endogenous RUNX2 could augment the sensitivity to GEM in AsPC-1 cells.